Mitsuo Katano
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines.
Journal: Anticancer research
Published: April 11, 2018
Development of Holistic Cancer Treatment Centering Cancer Patients - From the Standpoint of Hypoxia and Hedgehog Signaling
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 16, 2017
Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Under Hypoxia, Suppressing the Malignant Phenotype in Pancreatic Cancer.
Journal: Anticancer research
Published: May 06, 2016
Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.
Journal: Cancer letters
Published: August 17, 2015
Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Journal: International journal of cancer
Published: July 30, 2015
Surgical treatment to aid patients with colorectal perforation.
Journal: In vivo (Athens, Greece)
Published: September 06, 2014
An epithelial cell adhesion molecule- and CD3-bispecific antibody plus activated T-cells can eradicate chemoresistant cancer stem-like pancreatic carcinoma cells in vitro.
Journal: Anticancer research
Published: July 31, 2014
NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors.
Journal: Anticancer research
Published: July 31, 2014
Random migration contributes to cytotoxicity of activated CD8+ T-lymphocytes but not NK cells.
Journal: Anticancer research
Published: July 31, 2014
Last Updated: 09/26/2026